Research Excellence Award
Isa Ardahanli
Bilecik Şeyh Edebali University, Turkey
Isa Ardahanli is a researcher affiliated with Bilecik Şeyh Edebali University whose academic work focuses on hypertension, cardiovascular medicine, pharmacological interactions, and translational clinical research. The researcher has contributed to publications addressing aortic stiffness, antiplatelet therapy, heart failure management, and cardiovascular complications associated with pharmacological interventions. The scholarly profile demonstrates interdisciplinary engagement in cardiovascular sciences and clinical medicine with growing citation impact in peer-reviewed research.[1]
Abstract
The research activities of Isa Ardahanli involve cardiovascular medicine, hypertension management, pharmacological safety, and diagnostic assessment methodologies. Published studies and commentaries have explored aortic stiffness in subclinical hypothyroidism, dual antiplatelet therapy in coronary artery disease, and comparative therapeutic strategies in heart failure management. The researcher has also contributed to interdisciplinary investigations integrating artificial intelligence and spectrochemical analysis for critically ill patient assessment. These contributions reflect ongoing involvement in clinically relevant cardiovascular and translational research.[2]
Keywords
- Hypertension
- Cardiovascular Medicine
- Heart Failure
- Aortic Stiffness
- Clinical Pharmacology
- Artificial Intelligence in Medicine
Introduction
Cardiovascular research continues to emphasize the importance of diagnostic precision, pharmacological safety, and evidence-based therapeutic strategies. Studies addressing hypertension, antiplatelet therapy, and heart failure management are central to improving patient outcomes and reducing cardiovascular risk. Isa Ardahanli has contributed to these research areas through scholarly commentaries, collaborative investigations, and publications focused on cardiovascular pharmacology and clinical assessment techniques.[3]
Research Profile
According to available Scopus metrics, Isa Ardahanli has achieved 144 citations and an h-index of 7, indicating recognized scholarly engagement within cardiovascular medicine and hypertension research.[1] The publication record includes contributions to journals such as Acta Cardiologica, Talanta, and Arquivos Brasileiros de Cardiologia. Research themes include cardiovascular therapeutics, diagnostic methods, and interdisciplinary medical technologies.
Research Contributions
A notable contribution involves commentary on non-invasive oscillometric approaches for evaluating aortic stiffness in patients with subclinical hypothyroidism. This work discusses diagnostic methodologies relevant to cardiovascular risk stratification and vascular assessment.[2] The researcher has also participated in studies examining dual antiplatelet therapy among Turkish patients with coronary artery disease and analyses of therapeutic strategies in heart failure management. Additional interdisciplinary work integrated explainable artificial intelligence and spectrochemical methods to evaluate critically ill patients with COVID-19, demonstrating broader translational research engagement.[4]
Publications
- Commentary on the Role of Non-invasive Oscillometric Methods in Assessing Aortic Stiffness.
DOI Link
- Fixed-Dose Antiplatelet Dual Combination in Patients with Coronary Artery Disease.
DOI Link
- Spectrochemical and Explainable Artificial Intelligence Approaches for Critically Ill Patients with COVID-19.
DOI Link
Research Impact
The researcher’s publications contribute to discussions concerning cardiovascular risk management, therapeutic optimization, and innovative diagnostic methodologies. Collaborative studies addressing hypertension and cardiovascular pharmacology support evidence-based clinical practice and ongoing advancements in cardiovascular medicine.[5]
Award Suitability
Isa Ardahanli demonstrates suitability for the Research Excellence Award through contributions to hypertension research, cardiovascular therapeutics, and interdisciplinary clinical investigations. The publication record, citation performance, and engagement in cardiovascular-focused studies align with the objectives of the International Research Awards on Cardiology & Cardiovascular Medicine.[3]
Conclusion
Isa Ardahanli has contributed to cardiovascular medicine through research involving hypertension, vascular assessment, pharmacological evaluation, and translational healthcare technologies. The researcher’s interdisciplinary publications provide clinically relevant insights that support diagnostic innovation and evidence-based cardiovascular practice within contemporary medical research.[1]
External Links
References
- Elsevier. (n.d.). Scopus author details: Isa Ardahanli, Author ID 56520257000. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=56520257000
- Aslan, R., et al. (2026). Commentary on the Role of Non-invasive Oscillometric Methods in Assessing Aortic Stiffness in Subclinical Hypothyroidism.
https://doi.org/10.1080/00015385.2025.2453800
- Aslan, R., et al. (2025). Comparative Effectiveness of Torsemide and Furosemide in Heart Failure.
https://doi.org/10.1080/00015385.2025.2476890
- Tokgoz, G., et al. (2024). Spectrochemical and Explainable Artificial Intelligence Approaches for Molecular Identification in Critically Ill Patients.
https://doi.org/10.1016/j.talanta.2024.126652
- Oz, A., et al. (2024). Fixed-Dose Antiplatelet Dual Combination in Patients with Coronary Artery Disease in Turkish Population.
https://doi.org/10.36660/ABC.20240202I